课题基金 / 基金详情

70 KD HSPS--MODULATORS OF DEVELOPMENTAL TOXICITY

70 KD HSPS--MODULATORS OF DEVELOPMENTAL TOXICITY
70 KD HSPS--发育毒性调节剂
批准号:
2838228
负责人:
PHILIP E MIRKES
金额:
$26.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1996
资助国家:
美国
项目状态:
已结题
起止时间:
1996-12-01 至 2000-11-30

项目摘要

项目成果

PHILIP E MIRKES的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: Although a variety of physical and chemical agents disrupt development in animals and humans, little is known about factors that determine whether a particular animal or human will be sensitive to a potentially developmentally toxic exposure. Recent research has identified a family of genes and their respective proteins, known as 70 kilodalton heat shock protein (Hsp 70) family, that plays a role in protecting cells and organs from the toxic effects of exposure to hyperthermia and chemical insult. In addition, research from the author's laboratory and other laboratories has implicated these heat shock proteins as modulators of developmental toxicity in mammalian embryos. To determine more precisely the role of specific heat shock proteins in modulating developmental toxicity, three specific aims are proposed. In specific aim 1, it is proposed to use transgenic mice that overexpress specific heat shock proteins to test the hypothesis that overexpression of inducible Hsp70 will decrease the sensitivity of early postimplantation mouse embryos to the teratogenic effects of selected developmental toxicants. In specific aim 2, it is proposed to use transgenic mice in which the Hsp 70-1 and Hsp 70-3 genes have been inactivated by homologous recombination to test the hypothesis that loss of Hsp 70-1/3 will increase the sensitivity of early postimplantation mouse embryos to the transgenic effects of selected developmental toxicants. In specific aim 3, it is proposed to use these gain-of-function and loss-of-function transgenics to investigate the hypothesis that Hsp 70-1/3 exerts its modulating activity by interacting with the cell cycle machinery, thereby preventing inappropriate cell death. In the work proposed the developmental toxicants will be hyperthermia and cyclophosphamide.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PROTEOMIC APPROACH TO THE INDENTIFICATION OF PROTEINS*
  • 批准号:
    6629400
  • 项目类别:
  • 资助金额:
    $3.9万
  • 财政年份:
    2002
  • 负责人:
    PHILIP E MIRKES
  • 依托单位:
2002 TERATOLOGY SOCIETY MEETING: TRAVEL SUPPORT
  • 批准号:
    6505365
  • 项目类别:
  • 资助金额:
    $1.3万
  • 财政年份:
    2002
  • 负责人:
    PHILIP E MIRKES
  • 依托单位:
A PROTEOMIC APPROACH TO THE INDENTIFICATION OF PROTEINS*
  • 批准号:
    6501200
  • 项目类别:
  • 资助金额:
    $15.18万
  • 财政年份:
    2002
  • 负责人:
    PHILIP E MIRKES
  • 依托单位:
A PROTEOMIC APPROACH TO THE INDENTIFICATION OF PROTEINS*
  • 批准号:
    6924232
  • 项目类别:
  • 资助金额:
    $10.74万
  • 财政年份:
    2002
  • 负责人:
    PHILIP E MIRKES
  • 依托单位:
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2016
  • 负责人:
    陈昊
  • 依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 项目类别:
    面上项目
  • 资助金额:
    73.0万元
  • 批准年份:
    2014
  • 负责人:
    董家鸿
  • 依托单位: